The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
New research shows people in specific Polynesian communities have a much higher rate of a form of Parkinson’s disease ...
New research finds chronic pain is five times more common in patients with Parkinson’s disease compared to age-matched ...
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for ...
Medtronic's FDA-approved BrainSense Adaptive DBS system revolutionizes Parkinson's therapy with real-time adjustments for ...